
Inlyta 5mg Tablet
Marketer
Pfizer Ltd
Salt Composition
Axitinib (5mg)
Overview Inlyta 5mg Tablet
Axitinib 5mg tablets are a medication used to combat kidney cancer. This anti-cancer drug can be administered with or without food, but consistent daily timing maximizes effectiveness. Dosage and frequency are determined by your physician based on your specific condition and may adjust over time. Strictly adhere to your doctor's prescribed regimen; improper use or overdose can lead to severe adverse reactions. While benefits may not be apparent for weeks or months, discontinue use only under your doctor's instruction. Common side effects include elevated blood pressure, arthralgia, and decreased appetite. Diarrhea and dyspnea can sometimes become serious; address these promptly with prescribed medication or hydration. Regular blood pressure monitoring is often advised. Report severe headaches, disorientation, visual disturbances, nausea, or vomiting to your physician immediately. Before commencing treatment, disclose any thyroid disorders, hepatic impairment, bleeding issues, or the use of antimicrobial agents. Inform your healthcare provider of all medications you are currently taking due to potential interactions. This medication is contraindicated during pregnancy and lactation; reliable contraception is crucial for women undergoing treatment. A patient support/assistance program, facilitated by Tata 1mg, is accessible in India. Consult your physician or call (1800-102-1618) for program details.
Primary Ingredients of Inlyta 5mg Tablet
The provided text is "undefined," offering no content to rephrase. Therefore, no rewritten text can be provided.
Uses of Inlyta 5mg Tablet
Renal cell carcinoma
Major Benefits of Inlyta 5mg Tablet:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the 5mg Inlyta tablet whole; do not chew, crush, or fracture it. While this medication can be taken with or without food, consistency is key—take it at the same time each day.
Common Side effects of Inlyta 5mg Tablet:
- High blood pressure
- Joint pain
- Loss of appetite
- Diarrhea
- Breathing problems
- Abdominal pain
- Constipation
- Cough
- Decreased appetite
- Decreased level of thyroid hormones
- Difficulty in speaking
- Dry skin
- Indigestion
- Headache
- Nausea
- Pain in extremities
- Painful blisters on hands and feet
- Protein in urine
- Rash
- Breathlessness
- Stomatitis (Inflammation of the mouth)
- Taste change
- Vomiting
How to use Inlyta 5mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 5mg Inlyta tablet whole; avoid chewing, crushing, or breaking it. While it can be taken with or without food, consistency in timing is recommended.
How Inlyta 5mg Tablet works:
Sutent 5mg tablets are a cancer treatment that inhibits the activity of a protein responsible for the uncontrolled growth of cancerous cells, thereby suppressing or retarding tumor progression.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Inlyta 5mg Tablets may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Using Inlyta 5mg tablets during pregnancy poses a confirmed risk to the fetus. Therefore, it's contraindicated. Exceptionally, a physician might prescribe it in life-threatening cases where the potential benefits outweigh the known hazards. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Breastfeeding while taking Inlyta 5mg tablets is likely unsafe. Available human data indicates potential drug transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Taking a 5mg Inlyta tablet might cause drowsiness, blurred vision, or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
For patients with kidney disease, Inlyta 5mg tablets are considered safe and require no dosage modification.
LiverCAUTION
Patients with liver impairment should use Inlyta 5mg tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Data regarding Inlyta 5mg tablet use in patients exhibiting severe hepatic dysfunction is limited.
What if you forget to take Inlyta 5mg Tablet :
NA
Facts to Know About Inlyta 5mg Tablet
Label | Value |
---|---|
Chemical Category | Indazole and Enzamide Derivatives |
Developing Habits | No. |
Type of Therapy | Cancer Medications |
Action Class | TKIs (Tyrosine Kinase Inhibitors) |